主题：【海外名家讲堂】How the Pandemic and Other Recent Developments Have Impacted the Business Environment - from Supply Chain to Customers? A Business Insights & Analytics View
主讲人：德国拜耳公司 Robin Niethammer先生
主办单位：工商管理学院 国际交流与合作处 科研处
Robin Niethammer is a financial management, controlling and HR content matter expert with more than 20 years of experience, including work with multinational corporations such as Bayer, Siemens, and Nokia.
In his current role as global Separation Lead for Bayer Pharma, Robin is responsible for the successful separation of non-core assets to acquirers starting already before a due diligence. In his previous role as Director Business Insights & Analytics he observed and analyzed the changes in the competitive environment in the pharmaceutical business.
Robin spent 3 years in Chengdu, China, where he was the Head of CAO Region West China (CFO) for Bayer HealthCare covering 18 Chinese provinces. While in China, he served as Chairman and board member of the European Chamber of Commerce Southwest China. His leadership contributed significantly to the Chamber’s first published Regional Position Paper which - covered extensively by the media - was well received by the business community and the local government.
Robin attended Technical University (TU) Dresden in Germany from which he obtained a graduate degree in business management. He also studied in Belgium and Switzerland.
Robin Niethammer，德国德累斯顿工业大学商业管理硕士，拜耳医药集团全球产业分离负责人。作为财务管理与控制、人力资源方面的专家，Robin Niethammer先生在拜耳、西门子和诺基亚等跨国公司具有超过20年的工作经验。Robin Niethammer先生曾在成都工作3年，担任拜耳医药保健公司华西区（覆盖18个省份）首席行政官。在中国期间，还曾担任中国西南欧盟商会主席及董事会成员，对欧盟商会在华发展做出重大贡献，受到商界和当地政府的好评。
Due to the pandemic and other recent developments one can observe changes in customer behavior, uncertainties in product supply, new forms of business interaction. These are all challenges yet also opportunities to analyze business practices and renew or adjust processes. Certain innovations needed more time due to the Covid situation while other innovations, especially in the digital arena got a boost. The presentation will explain in general the above topics and will focus in particular on the pharmaceutical industry.